IBDEI0QI ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11927,1,2,0)
 ;;=2^J2182
 ;;^UTILITY(U,$J,358.3,11927,1,3,0)
 ;;=3^MEPOLIZUMAB 1MG
 ;;^UTILITY(U,$J,358.3,11928,0)
 ;;=J1568^^48^580^81^^^^1
 ;;^UTILITY(U,$J,358.3,11928,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11928,1,2,0)
 ;;=2^J1568
 ;;^UTILITY(U,$J,358.3,11928,1,3,0)
 ;;=3^OCTAGAM 500MG
 ;;^UTILITY(U,$J,358.3,11929,0)
 ;;=J3357^^48^580^107^^^^1
 ;;^UTILITY(U,$J,358.3,11929,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11929,1,2,0)
 ;;=2^J3357
 ;;^UTILITY(U,$J,358.3,11929,1,3,0)
 ;;=3^USTEKINUMAB 1MG
 ;;^UTILITY(U,$J,358.3,11930,0)
 ;;=J9030^^48^580^18^^^^1
 ;;^UTILITY(U,$J,358.3,11930,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11930,1,2,0)
 ;;=2^J9030
 ;;^UTILITY(U,$J,358.3,11930,1,3,0)
 ;;=3^BCG LIVE INTRAVESICAL INSTILLATION,1MG
 ;;^UTILITY(U,$J,358.3,11931,0)
 ;;=J0897^^48^580^30^^^^1
 ;;^UTILITY(U,$J,358.3,11931,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11931,1,2,0)
 ;;=2^J0897
 ;;^UTILITY(U,$J,358.3,11931,1,3,0)
 ;;=3^DENOSUMAB 1MG (Prolia)
 ;;^UTILITY(U,$J,358.3,11932,0)
 ;;=J0400^^48^580^12^^^^1
 ;;^UTILITY(U,$J,358.3,11932,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11932,1,2,0)
 ;;=2^J0400
 ;;^UTILITY(U,$J,358.3,11932,1,3,0)
 ;;=3^ARIPIPRAZOLE 0.25MG
 ;;^UTILITY(U,$J,358.3,11933,0)
 ;;=J0401^^48^580^14^^^^1
 ;;^UTILITY(U,$J,358.3,11933,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11933,1,2,0)
 ;;=2^J0401
 ;;^UTILITY(U,$J,358.3,11933,1,3,0)
 ;;=3^ARIPIPRAZOLE,EXT RELEASE,1MG
 ;;^UTILITY(U,$J,358.3,11934,0)
 ;;=J1944^^48^580^13^^^^1
 ;;^UTILITY(U,$J,358.3,11934,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11934,1,2,0)
 ;;=2^J1944
 ;;^UTILITY(U,$J,358.3,11934,1,3,0)
 ;;=3^ARIPIPRAZOLE LAUROXIL 1MG
 ;;^UTILITY(U,$J,358.3,11935,0)
 ;;=Q0245^^48^580^17^^^^1
 ;;^UTILITY(U,$J,358.3,11935,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11935,1,2,0)
 ;;=2^Q0245
 ;;^UTILITY(U,$J,358.3,11935,1,3,0)
 ;;=3^BAMLIANIVIMAB/ETESEVIMA 2100MG
 ;;^UTILITY(U,$J,358.3,11936,0)
 ;;=J0485^^48^580^16^^^^1
 ;;^UTILITY(U,$J,358.3,11936,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11936,1,2,0)
 ;;=2^J0485
 ;;^UTILITY(U,$J,358.3,11936,1,3,0)
 ;;=3^BALATACEPT 1MG
 ;;^UTILITY(U,$J,358.3,11937,0)
 ;;=Q5104^^48^580^53^^^^1
 ;;^UTILITY(U,$J,358.3,11937,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11937,1,2,0)
 ;;=2^Q5104
 ;;^UTILITY(U,$J,358.3,11937,1,3,0)
 ;;=3^INFLEXIMAB-ABDA RENIFLEXIS 100MG
 ;;^UTILITY(U,$J,358.3,11938,0)
 ;;=Q0139^^48^580^58^^^^1
 ;;^UTILITY(U,$J,358.3,11938,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11938,1,2,0)
 ;;=2^Q0139
 ;;^UTILITY(U,$J,358.3,11938,1,3,0)
 ;;=3^IRON FERUMOXYTOL 1MG
 ;;^UTILITY(U,$J,358.3,11939,0)
 ;;=J9312^^48^580^98^^^^1
 ;;^UTILITY(U,$J,358.3,11939,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11939,1,2,0)
 ;;=2^J9312
 ;;^UTILITY(U,$J,358.3,11939,1,3,0)
 ;;=3^RITUXIMAB 10MG
 ;;^UTILITY(U,$J,358.3,11940,0)
 ;;=J3241^^48^580^102^^^^1
 ;;^UTILITY(U,$J,358.3,11940,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11940,1,2,0)
 ;;=2^J3241
 ;;^UTILITY(U,$J,358.3,11940,1,3,0)
 ;;=3^TEPROTUMUMAB-TRBW 10MG
 ;;^UTILITY(U,$J,358.3,11941,0)
 ;;=86580^^48^581^12^^^^1
 ;;^UTILITY(U,$J,358.3,11941,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11941,1,2,0)
 ;;=2^86580
 ;;^UTILITY(U,$J,358.3,11941,1,3,0)
 ;;=3^TB INTRADERMAL TEST
 ;;^UTILITY(U,$J,358.3,11942,0)
 ;;=82948^^48^581^5^^^^1
 ;;^UTILITY(U,$J,358.3,11942,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11942,1,2,0)
 ;;=2^82948
